loading
前日終値:
$112.53
開ける:
$110.21
24時間の取引高:
441.21K
Relative Volume:
0.59
時価総額:
$7.38B
収益:
$217.17M
当期純損益:
$-202.68M
株価収益率:
-46.54
EPS:
-2.3028
ネットキャッシュフロー:
$-156.63M
1週間 パフォーマンス:
-2.57%
1か月 パフォーマンス:
-0.81%
6か月 パフォーマンス:
+15.57%
1年 パフォーマンス:
+2.82%
1日の値動き範囲:
Value
$107.09
$114.75
1週間の範囲:
Value
$107.09
$114.75
52週間の値動き範囲:
Value
$74.50
$122.20

Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile

Name
名前
Rhythm Pharmaceuticals Inc
Name
セクター
Healthcare (1080)
Name
電話
857-264-4280
Name
住所
222 BERKELEY STREET, BOSTON, MA
Name
職員
414
Name
Twitter
@rhythmpharma
Name
次回の収益日
2026-08-04
Name
最新のSEC提出書
Name
RYTM's Discussions on Twitter

Compare RYTM vs VRTX, REGN, ARGX, MRNA, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
RYTM icon
RYTM
Rhythm Pharmaceuticals Inc
107.17 7.50B 217.17M -202.68M -156.63M -2.3028
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
541.69 136.93B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
794.19 85.11B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
1,023.21 64.95B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
137.99 53.23B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
207.88 45.38B 742.00K -1.37B -1.07B -7.0731

Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-02-19 開始されました RBC Capital Mkts Outperform
2025-11-25 開始されました Citigroup Buy
2025-11-05 ダウングレード Oppenheimer Outperform → Perform
2025-07-10 開始されました Goldman Buy
2025-07-07 開始されました Leerink Partners Outperform
2025-04-07 アップグレード BofA Securities Neutral → Buy
2025-03-05 再開されました Stifel Buy
2025-01-02 開始されました Jefferies Buy
2024-12-20 開始されました Oppenheimer Outperform
2024-10-21 開始されました Guggenheim Buy
2024-09-18 開始されました H.C. Wainwright Buy
2024-09-17 開始されました JMP Securities Mkt Outperform
2024-05-08 ダウングレード BofA Securities Buy → Neutral
2023-12-19 アップグレード Morgan Stanley Equal-Weight → Overweight
2023-08-01 アップグレード BofA Securities Neutral → Buy
2023-01-18 再開されました Canaccord Genuity Buy
2022-08-08 アップグレード Goldman Neutral → Buy
2022-08-05 アップグレード BofA Securities Underperform → Neutral
2022-06-17 繰り返されました Needham Buy
2022-03-02 再開されました Stifel Buy
2022-02-17 アップグレード Ladenburg Thalmann Neutral → Buy
2021-12-08 開始されました Wells Fargo Overweight
2021-11-19 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-09-14 再開されました Goldman Neutral
2021-08-04 ダウングレード BofA Securities Neutral → Underperform
2021-08-04 ダウングレード Ladenburg Thalmann Buy → Neutral
2020-11-30 ダウングレード BofA Securities Buy → Neutral
2020-01-08 開始されました Goldman Sell
2019-07-12 アップグレード Stifel Hold → Buy
2019-07-08 開始されました Canaccord Genuity Buy
2019-03-13 開始されました Ladenburg Thalmann Buy
2018-09-07 再開されました Morgan Stanley Overweight
2018-06-25 繰り返されました Needham Buy
2018-06-15 繰り返されました Needham Buy
2017-10-30 開始されました BofA/Merrill Buy
2017-10-30 開始されました Needham Buy
すべてを表示

Rhythm Pharmaceuticals Inc (RYTM) 最新ニュース

pulisher
Aug 21, 2026

Blue Owl Capital Holdings LP Invests $6.82 Million in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat

Aug 21, 2026
pulisher
Aug 20, 2026

TD Cowen Names Rhythm Pharmaceuticals Its Top Pick Following Robust Q2 Results - StockInvest.us

Aug 20, 2026
pulisher
Aug 18, 2026

Rhythm Pharmaceuticals (RYTM) grants CMO 50K options expiring 2036 - Stock Titan

Aug 18, 2026
pulisher
Aug 18, 2026

Rhythm (RYTM) CMO reports no company stock holdings - Stock Titan

Aug 18, 2026
pulisher
Aug 18, 2026

Rhythm Pharmaceuticals (RYTM) Stock Looks Pricey Following Strong IMCIVREE News - Sahm

Aug 18, 2026
pulisher
Aug 18, 2026

Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer - Sahm

Aug 18, 2026
pulisher
Aug 18, 2026

Rhythm Pharmaceuticals: Building A Defensive MC4R Franchise (NASDAQ:RYTM) - Seeking Alpha

Aug 18, 2026
pulisher
Aug 18, 2026

Rhythm Pharma files Form 3 for Chief Medical Officer Manher Joshi - Bitget

Aug 18, 2026
pulisher
Aug 17, 2026

Rhythm Pharmaceuticals CTO Joseph Shulman sells $608,210 of stock - Investing.com

Aug 17, 2026
pulisher
Aug 17, 2026

Rhythm Pharmaceuticals CTO Joseph Shulman sells $608,210 of stock By Investing.com - Investing.com India

Aug 17, 2026
pulisher
Aug 17, 2026

Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Alastair Garfield Sells 7,763 Shares - MarketBeat

Aug 17, 2026
pulisher
Aug 17, 2026

Insider Selling: Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Sells 5,079 Shares of Stock - MarketBeat

Aug 17, 2026
pulisher
Aug 17, 2026

Rhythm Pharmaceuticals CSO Alastair Garfield sells $912,703 in stock By Investing.com - Investing.com Canada

Aug 17, 2026
pulisher
Aug 17, 2026

Rhythm Pharmaceuticals CSO Alastair Garfield sells $912,703 in stock - Investing.com

Aug 17, 2026
pulisher
Aug 17, 2026

Rhythm (NASDAQ: RYTM) CTO sells 5,079 shares in 10b5-1 plan - Stock Titan

Aug 17, 2026
pulisher
Aug 17, 2026

Rhythm Pharmaceuticals Eyes AHO Growth, Global IMCIVREE Expansion and Pipeline Catalysts - NewsBreak: Local News & Alerts

Aug 17, 2026
pulisher
Aug 17, 2026

Rhythm Pharmaceuticals Announces Appointment Of Manher (Aj) Joshi As Chief Medical Officer - TradingView

Aug 17, 2026
pulisher
Aug 17, 2026

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 22.56% Potential Upside on Robust Analyst Confidence - DirectorsTalk Interviews

Aug 17, 2026
pulisher
Aug 17, 2026

BRIEF-Rhythm Pharmaceuticals Announces Appointment Of Manher (Aj) Joshi As Chief Medical Officer - Bitget

Aug 17, 2026
pulisher
Aug 16, 2026

Enterprise value to revenue forward of Rhythm Pharmaceuticals, Inc. – DUS:1RV - TradingView

Aug 16, 2026
pulisher
Aug 15, 2026

Rhythm Pharmaceuticals(RYTM.US) Officer Sells US$8.9 Million in Common Stock - Moomoo

Aug 15, 2026
pulisher
Aug 15, 2026

Rhythm Pharmaceuticals EVP Mazabraud sells $6.6m in stock By Investing.com - Investing.com Nigeria

Aug 15, 2026
pulisher
Aug 14, 2026

Rhythm Pharmaceuticals EVP Jennifer Kayden Lee Executes Stock Options and Sells Shares Under 10b5-1 Plan - Kalkine Media

Aug 14, 2026
pulisher
Aug 14, 2026

Rhythm Pharmaceuticals EVP Yann Mazabraud Executes Stock Option and Sells Shares Under Rule 10b5-1 Plan - Kalkine Media

Aug 14, 2026
pulisher
Aug 14, 2026

Rhythm Pharmaceuticals (NASDAQ:RYTM) EVP Yann Mazabraud Sells 57,000 Shares - MarketBeat

Aug 14, 2026
pulisher
Aug 14, 2026

Insider Selling: Rhythm Pharmaceuticals (NASDAQ:RYTM) EVP Sells 75,834 Shares of Stock - MarketBeat

Aug 14, 2026
pulisher
Aug 14, 2026

Rhythm Pharmaceuticals EVP, Jennifer Lee, sells $8.9m in stock By Investing.com - Investing.com Australia

Aug 14, 2026
pulisher
Aug 14, 2026

Rhythm Pharmaceuticals EVP Mazabraud sells $6.6m in stock - Investing.com

Aug 14, 2026
pulisher
Aug 14, 2026

Rhythm Pharmaceuticals EVP, Jennifer Lee, sells $8.9m in stock - Investing.com

Aug 14, 2026
pulisher
Aug 14, 2026

Rhythm Pharmaceuticals (RYTM) EVP exercises 56,601 options and sells 75,834 shares - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Rhythm Pharmaceuticals (RYTM) EVP sells 57K shares after $6.80 option exercise - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Rhythm Pharmaceuticals (RYTM) Q2 2026 Earnings Call Transcript - AOL.com

Aug 14, 2026
pulisher
Aug 14, 2026

Dimensional Fund Advisors LP Sells 12,867 Shares of Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat

Aug 14, 2026
pulisher
Aug 14, 2026

How Investors Are Reacting To Rhythm Pharmaceuticals (RYTM) UK Orphan Expansion For IMCIVREE In Hypothalamic Obesity - Sahm

Aug 14, 2026
pulisher
Aug 13, 2026

RHYTHM PHARMACEUTICALS, INC. SEC Filing (Aug 13, 2026) - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

RYTM (NASDAQ: RYTM) investor plans sale of 5,079 shares worth $597K - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

RYTM (RYTM) insider plans Form 144 sale of option and RSU shares - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Price, News, Quote & History - Yahoo! Finance Canada

Aug 13, 2026
pulisher
Aug 12, 2026

Trading the Move, Not the Narrative: (RYTM) Edition - Stock Traders Daily

Aug 12, 2026
pulisher
Aug 12, 2026

Rhythm Pharmaceuticals (RYTM) plans 57,000-share stock sale via broker - Stock Titan

Aug 12, 2026
pulisher
Aug 12, 2026

Rhythm Pharmaceuticals (RYTM) Advances 2.94% to $116.16 as Bullish Momentum BuildsLong Setup Ideas - vinanet.vn

Aug 12, 2026
pulisher
Aug 12, 2026

Why Is Rhythm Pharmaceuticals Stock Trading Higher On Wednesday? - TradingView

Aug 12, 2026
pulisher
Aug 12, 2026

Rhythm Pharmaceuticals at Canaccord Genuity: launch gains widen - Investing.com

Aug 12, 2026
pulisher
Aug 12, 2026

Rhythm Pharmaceuticals (RYTM) Slips 2.28% to $112.84 as Shares Hold Mid-RangeETH Profile - vinanet.vn

Aug 12, 2026
pulisher
Aug 12, 2026

Bank of America Corp DE Grows Stake in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat

Aug 12, 2026
pulisher
Aug 11, 2026

Rhythm Pharmaceuticals (RYTM) insider outlines 10b5-1 stock sale plan in Form 144 - Stock Titan

Aug 11, 2026
pulisher
Aug 11, 2026

Rhythm Pharmaceuticals, Inc. (RYTM) stock price, news, quote and history - Yahoo Finance UK

Aug 11, 2026
pulisher
Aug 11, 2026

Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury - The Manila Times

Aug 11, 2026
pulisher
Aug 11, 2026

Rhythm Pharmaceuticals Announces UK MHRA Expansion of IMCIVREE for Acquired Hypothalamic Obesity - Quiver Quantitative

Aug 11, 2026
pulisher
Aug 11, 2026

Rhythm's IMCIVREE authorized in UK for obesity after hypothalamic injury - Stock Titan

Aug 11, 2026
pulisher
Aug 11, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: Orthofix Medical (OFIX), Rhythm Pharmaceuticals (RYTM) and Viatris (VTRS) - The Globe and Mail

Aug 11, 2026

Rhythm Pharmaceuticals Inc (RYTM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Rhythm Pharmaceuticals Inc (RYTM) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Shulman Joseph
Chief Technical Officer
Aug 13 '26
Sale
119.75
5,079
608,210
15,915
Garfield Alastair
Chief Scientific Officer
Aug 13 '26
Sale
117.57
7,763
912,703
2,295
Lee Jennifer Kayden
EVP, Head of North America
Aug 13 '26
Option Exercise
17.62
56,601
997,037
75,834
Lee Jennifer Kayden
EVP, Head of North America
Aug 13 '26
Sale
117.38
75,834
8,901,531
0
Mazabraud Yann
EVP, Head of International
Aug 12 '26
Option Exercise
6.80
46,625
317,050
112,655
Mazabraud Yann
EVP, Head of International
Aug 12 '26
Sale
116.15
57,000
6,620,575
55,655
$102.08
price down icon 8.37%
$118.54
price down icon 2.35%
$60.85
price down icon 1.73%
$237.10
price up icon 0.23%
ONC ONC
$366.73
price down icon 1.55%
$207.88
price down icon 6.00%
大文字化:     |  ボリューム (24 時間):